Compare Edgewise Therapeutics Inc. Common Stock (EWTX) vs Nu Holdings Ltd (NU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edgewise Therapeutics Inc. Common Stock vs Nu Holdings Ltd — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $38.06 (market cap $4.02B), while Nu Holdings Ltd trades at $14.87 (market cap $72.12B). The key difference: Nu Holdings Ltd is far larger — about 17.9× Edgewise Therapeutics Inc. Common Stock's market cap, and Edgewise Therapeutics Inc. Common Stock is trading nearer its 52-week high, Nu Holdings Ltd nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and Nu Holdings Ltd for 53 Days on average.
| EWTX | NU | |
|---|---|---|
Market Cap | $4.02B | $72.12B |
Volume | 1,446,128 | 81,811,728 |
Sector | Health | Financials |
52-Week High | $48.35 | $18.76 |
52-Week Low | $14.89 | $11.60 |
Typical Hold Time | 0 Days | 53 Days |
Enterprise Value | $3.56B | $94.54B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
NU Holdings (NU) trades at $14.93, down 4.17% today, with a mixed technical picture showing bullish moving averages but neutral oscillators. The company demonstrates strong fundamental momentum with revenue growing from $3.0B in 2022 to $10.6B in 2025 and net income turning positive to $2.9B. Recent news highlights acquisition speculation and Goldman Sachs' bullish stance, while analysts maintain a Buy consensus with a $16.53 target.
The outlook remains positive given NU's expanding customer base and profitability improvements, though risks include credit quality concerns and competitive pressures. With 56.5% analyst Buy ratings and a price target 10.7% above current levels, the stock presents growth potential but requires monitoring of execution risks and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Edgewise Therapeutics Inc. Common Stock
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →About Nu Holdings Ltd
Nu Holdings Ltd is engaged in providing digital banking services. It offers several financial services such as Credit cards, Personal Account, Investments, Personal Loans, Insurance, Mobile payments, Business Account, and Rewards.
Read more on NU →
